Published in Hepatitis Weekly, May 15th, 2000
An added advantage is that fewer injections are required.
Zuckerman reported her findings at the 10th International Symposium on Viral Hepatitis and Liver Disease, held recently in Atlanta, Georgia. The title of her study presentation was "Rapid Protection Against Hepatitis A and B Following Accelerated Schedule of a Combined Hepatitis A/B Vaccine."
In a multi-center,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.